Tweetable abstract Herpes zoster (HZ) is a vaccine-preventable disease, but the role of the vaccine in cancer patients during immunotherapy (ICIs) is still unknown. The clinical and economic consequences of HZ and the increased use of ICIs require a greater awareness by the oncologist.
All Keywords
【저자키워드】 Immunotherapy, Cancer, T-cell Response, prevention, PD-L1, Immune checkpoint inhibitors, herpes zoster, viral reactivation, HZ, RZV vaccine,
【저자키워드】 Immunotherapy, Cancer, T-cell Response, prevention, PD-L1, Immune checkpoint inhibitors, herpes zoster, viral reactivation, HZ, RZV vaccine,